Literature DB >> 12230555

The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein.

Michael R Food1, Eric O Sekyere, Des R Richardson.   

Abstract

Melanotransferrin (MTf) is a membrane-bound transferrin (Tf) homologue found particularly in melanoma cells. Apart from membrane-bound MTf, a soluble form of the molecule (sMTf) has been identified in vitro[Food, M.R., Rothenberger, S., Gabathuler, R., Haidl, I.D., Reid, G. & Jefferies, W.A. (1994) J. Biol. Chem.269, 3034-3040] and in vivo in Alzheimer's disease. However, nothing is known about the function of sMTf or its role in Fe uptake. In this study, sMTf labelled with 59Fe and 125I was used to examine its ability to donate 59Fe to SK-Mel-28 melanoma cells and other cell types. sMTf donated 59Fe to cells at 14% of the rate of Tf. Analysis of sMTf binding showed that unlike Tf, sMTf did not bind to a saturable Tf-binding site. Studies with Chinese hamster ovary cells with and without specific Tf receptors showed that unlike Tf, sMTf did not donate its 59Fe via these pathways. This was confirmed by experiments using lysosomotropic agents that markedly reduced 59Fe uptake from Tf, but had far less effect on 59Fe uptake from sMTf. In addition, an excess of 56Fe-labelled Tf or sMTf had no effect on 125I-labelled sMTf uptake, suggesting a nonspecific interaction of sMTf with cells. Protein-free 125I determinations demonstrated that in contrast with Tf, sMTf was markedly degraded. We suggest that unlike the binding of Tf to specific receptors, sMTf was donating Fe to cells via an inefficient mechanism involving nonspecific internalization and subsequent degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230555     DOI: 10.1046/j.1432-1033.2002.03140.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  A novel murine protein with no effect on iron homoeostasis is homologous with transferrin and is the putative inhibitor of carbonic anhydrase.

Authors:  Fudi Wang; Adam P Lothrop; Nicholas G James; Tanya A M Griffiths; Lisa A Lambert; Rachael Leverence; Igor A Kaltashov; Nancy C Andrews; Ross T A MacGillivray; Anne B Mason
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

2.  Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease.

Authors:  Richard R Desrosiers; Yanick Bertrand; Quynh-Tran Nguyen; Michel Demeule; Reinhard Gabathuler; Malcolm L Kennard; Serge Gauthier; Richard Béliveau
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 3.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.

Authors:  Rikki A M Brown; Kirsty L Richardson; Tasnuva D Kabir; Debbie Trinder; Ruth Ganss; Peter J Leedman
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

4.  Complex of human Melanotransferrin and SC57.32 Fab fragment reveals novel interdomain arrangement with ferric N-lobe and open C-lobe.

Authors:  Kristyn Hayashi; Kenton L Longenecker; Yi-Liang Liu; Bryan Faust; Aditi Prashar; Johannes Hampl; Vincent Stoll; Sandro Vivona
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 5.  Iron: An Essential Element of Cancer Metabolism.

Authors:  Myriam Y Hsu; Erica Mina; Antonella Roetto; Paolo E Porporato
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

6.  ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells.

Authors:  A Bohlken; B B Cheung; J L Bell; J Koach; S Smith; E Sekyere; W Thomas; M Norris; M Haber; D B Lovejoy; D R Richardson; G M Marshall
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.